Combined Oral Contraceptives

Perceived pain and sedation dosing during abortion procedures by demographics, PAPP-A as a novel screening for gestational age before medication abortion, patient experiences with progestin-only pills and attitudes towards OTC access.

A systemic review of “no-test” medication abortion, using an allis clamp during IUD placement, a trial of gabapentin for pain management during second-trimester abortions, and at-home urine pregnancy testing for follow-up of immediate management of an undesired pregnancy of unknown location.

#IUD on TikTok, factors associated with pain during medication abortion, continuation rates of IUDs placed as EC at one year, and racial differences in birth control method provision for adolescents.

Health care provider misconceptions about birth control as an abortifacient, a comprehension study of an over-the-counter combination birth control pill label, an updated Consensus from ACOG on menstrual suppression, and the effect of state-level abortion restrictions on early pregnancy loss management.

Pregnancy intentions and outcomes in transgender, non-binary, and gender-expansive populations, PMS and PMDD treatment with OCPs, HPV vaccination in boys and men, increasing PreP awareness through more culturally competent materials, and more.

Novel ulipristal-releasing copper IUD, internal medicine physicians’ provision of medication abortion in a primary care setting, analysis of contraceptive decision aids for adolescents and young adults, and more.

Usage of combined oral contraceptives to manage PMS and PMDD symptoms, surgical abortion pain management for patients with opioid use disorder, risks associated with post-placental IUD placement, and more.

Pre-treatment with mifepristone for pain management in first-trimester surgical abortion care, high patient and provider satisfaction with telemedicine contraceptive counseling, an update to the CDC’s recommendation on self-administered DMPA-SC, and more.